Blog

Michael Gieske: Rewarding to join my friends in presenting Mass General Hospital Grand Rounds

Michael Gieske/LinkedIn

Jan 3, 2025, 12:29

Michael Gieske: Rewarding to join my friends in presenting Mass General Hospital Grand Rounds

Michael Gieske, Physician Director, Lung Cancer Screening at shared a post on LinkedIn:

“So enlightening and rewarding to join my friends in presenting Mass General Hospital Grand Rounds this month! An opportunity to share our community outreach, research, advocacy, and the success we’ve demonstrated in a decade of lung cancer screening.

Got to tour the hosp and visit the Ether Dome Theatre where ether was first used for general anesthesia. The WRP4LC in tow; as well visited Foundation Medicine Lab where they are doing tremendous work with human genetics testing and precision cancer treatment, and their special tribute to the White Ribbon Project! Making a difference!”

Michael Gieske

Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared this post on LinkedIn, adding:

“‘You’ll be on your way up! You’ll be seeing great sights! You’ll join the high fliers who soar to high heights.’ -Dr. Seuss

This is a testament to what can be achieved by any team – even at a community hospital – when you dream big and work hard. This team started with a critical problem, tackled it collaboratively, and shared their methods freely to help others.

And now, a family practice doctor from Northern Kentucky is giving Grand Rounds at Massachusetts General.

To anyone who questions their ability to make an impact at the highest levels: dream BIG, believe in your capacity to lead change, and put in the work to make it happen.

Congratulations to Dr. Gieske and the entire team—your work inspires us all!”

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health and the Leader of the AI and HealthCare Team for the Cincinnati AI Catalyst (CaiC).

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.